NSCLC	Non-small cell lung cancer
ICI	Immune checkpoint inhibitor
irAE	Immune related adverse event
ED	Emergency Department
IMU	Intermediate Care Unit
ICU	Intensive Care Unit
OS	Overall survival
PFS	Progression free survival
OR	Odds ratio
CI	Confidence interval
ECOG	Eastern Cooperative Oncology Group
PCR	Polymerase Chain Reaction
SSTI	soft tissue/skin infection
UTI	Urinary Tract Infection
HBV	Hepatitis B Virus
HCV	Hepatitis C Virus
HIV	Human Immunodeficiency
HNSCC	Head and Neck Squamous Cell Carcinoma
ESCMID	European Society of Clinical Microbiology and Infectious Diseases
RR	Relative Risk
PD-1	Programmed Death-1